MYABOV Trademark

Trademark Overview


On Tuesday, May 21, 2019, a trademark application was filed for MYABOV with the United States Patent and Trademark Office. The USPTO has given the MYABOV trademark a serial number of 79262375. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2020. This trademark is owned by Bio-Thera Solutions, Ltd.. The MYABOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases
myabov

General Information


Serial Number79262375
Word MarkMYABOV
Filing DateTuesday, May 21, 2019
Status700 - REGISTERED
Status DateTuesday, May 5, 2020
Registration Number6044633
Registration DateTuesday, May 5, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBio-Thera Solutions, Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGuangdong Province
CN

Party NameBio-Thera Solutions, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGuangdong Province
CN

Party NameBio-Thera Solutions, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGuangdong Province
CN

Trademark Events


Event DateEvent Description
Tuesday, July 16, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, August 7, 2019ASSIGNED TO EXAMINER
Thursday, July 4, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 8, 2019NON-FINAL ACTION WRITTEN
Friday, August 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 4, 2019REFUSAL PROCESSED BY MPU
Friday, September 20, 2019REFUSAL PROCESSED BY IB
Wednesday, September 4, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 13, 2019ASSIGNED TO LIE
Wednesday, January 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 10, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 29, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 29, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, February 14, 2020NOTIFICATION PROCESSED BY IB
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, August 5, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 16, 2020FINAL DISPOSITION PROCESSED
Wednesday, September 16, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 5, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED